-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H1u/fO7pxQLzkKD+YOyA9KawHpSP+VylQ/hdQr4ElhzMRShezbNkbaOAmSnoGICi RRMcUeqdhA+MJreUonjemw== 0000000000-07-036296.txt : 20070910 0000000000-07-036296.hdr.sgml : 20070910 20070726093505 ACCESSION NUMBER: 0000000000-07-036296 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070726 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 PUBLIC REFERENCE ACCESSION NUMBER: 0000950135-07-000981 LETTER 1 biognnfc.pdf NO FURTHER COMMENT LETTER 12/31/06 10-K MAST/HARTZ begin 644 biognnfc.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH@/#PO3&EN96%R:7IE9"`Q+TP@,3`P M.#DO3R`X+T4@-3DW,B].(#$O5"`Y.3(S+T@@6R`U-38@,38S73X^#65N9&]B M:@T@("`@("`@("`@("`@("`@("`@("`@#0IXF4@ M,3DO4')E=B`Y.3$S+U)O;W0@-R`P(%(O26YF;R`U(#`@4B])1%L\,48Y0T0R M,T-$.$,X.3(W-T0W,3$T,4-"0T$P-$4V.$0^/$1!.3(V-4$X1$,Y138V-#A" M0S!",$)%0T5#1CDX,S)&/ET^/@T*8')`$N:"8@4&)@8?U0)BDL*S8`H8E&R[P)FB!A1D9 M&,0V0G5;`#$K`X.J)427!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:CP\+T-O;&]R4W!A8V4\/"]# M'1'4W1A=&4\/"]'4S$@,3<@,"!2/CX^/@UE M;F1O8FH-,3`@,"!O8FH\/"]3=6)T>7!E+U1R=654>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH-,3$@,"!O8FH\ M/"],96YG=&@@-S8R+T9I;'1E\5Z:>/!$HHI9'RX>[%%^O!OI<9++*\E5LG)H$M2P%9 MM8+O9$G@:R9+<'ZE5]I^"*_URZY^@I`R.A'R_UY7N_(5>#@#KEA,$S;)H3H[ MFJXW,/<,B8;`K>A$`S<$KD59UD4QF-)$6>KSC)E,7?P1^:Z3SP+NG8B$MG3P M7&SG`FX;T3J^4JU$Y03$M[L9+&255;G)YGPCQ;K7R*R$;^NUS#&RSFT?;X#* M!ZA<0SV3=2$JN%R)?`:754Z.<>JS_F#F&\3,AWGFN`&B5-7E]J-#$5PC5X6` MN:BZ20B'.C_8RCI$NRT2CI6UL9W!UU.@G/G\C?G0B=C/ONEG[[@.Q^0>[#OQ M&3"5/*!31)5_UWN7:E\;=,"C@&()!FE1-UM@U+V&==U@\ML\T[4I3=W@I\@: MN*A68@7G(A?;1\R&IT\PW5JA"3[,YCA+G$3!:!Z/6()CT9Y:K:G>^- MU:ORQ`*2H"/Z06.H`CI8**RA:L/8OM;#I/U7-:QW3;?!FF$H=0S;N>W;A<7: M]QNH;%A]K%]]60?=Q@E)9,L6.ER`"2Y`@2,2V&1J[<&^$OOBF[YCB%BOO(/) M8=]PCT1^TH>#I<1]T(CR=3;I_=W-/0JWWX`.1[\XF%()D9YO['HE@!)PDM2# MV\2\*:4?V'=&61MENW7!E+U1R=654>7!E+T9O;G1$ M97-C7!E+T9O;G0^/@UE;F1O M8FH-,3,@,"!O8FI;+TE#0T)AD)6PPV,-6X"P M!I`U;&&1'011"$D(`1)"2-@%040%%$5$A*J5,M9M=$9/19TNKF.M#M9]ZM(# M]3#JZ#BT%M>.G1 MO>=\YCG:Q`J-5H&S*6>=0J,P\6F<5]<9E3@CJ3AWU:F5]3A?Q=FERJA1X_S< M%*M1RFH!0.DFNT$I+\?9#V>Z/B=+@O,"`,ATU3M<^@X;E`T&TZ4DU;I&O5I5 M;L#SM.3S+F>0?P+;VT_YU<]"H!X%J_-^K>VTBT`C*\$ MP/+F6YO+^P`P\;X=OOC.??BF>2DW&'1AOK[U]?4^:J7&W6*M0&=;464VO_4Q-_9=A/-#_7N+ACKP&OV`>P+O(`\K<+`.72 M`%*T#=^!WO0ME9(',O`UW^'>_-S/"?KW4^$^TZ-6K9J+DV3E8'*COFY^S_19 M`@*@`B;@`2M@#YR!.Q`"?Q`"PD$TB`?)(!WD@`*P%,A!.=``/:@'+:`==($> ML!YL`L-@.Q@#N\%^!P_!H_`^ M^#!\`CX/7X,GX8?P+`(0&L)''!$A(D8D2#I2B)0A>J05Z48&D5%D/W(,.8M< M02:11\@+E(AR40P5HN%H$IJ+RM$:M!7M18?17>AA]#1Z!9U"9]#7!`;!EN!% M""-("8L(*D(]H8LP2-A)^(APAG"-,$UX2B02^40!,8281"P@5A";B;W$K<0# MQ./$2\2[Q%D2B61%\B)%D-)),I*!U$7:0MI'^HQTF31->DZFD1W(_N0$8C%H7EQI*P9*Q6U@CK*.L&:Y;-98O8Z6P-NY>] MAWV.?9]#XKAQXCD*3B?G`\XISETNPG7F2KAR[@KN&/<,=YI'Y`EX4EX%KX?W M6]X$;\:<8QYHGF?>8#YB_HGY)!_AN_&E_"I^'_\@_SK_I86=18R%TF*-Q7Z+ MRQ;/+&TLHRV5EMV6!RRO6;ZTPJSBK2JM-EB-6]VQ1JT]K3.MZZVW69^Q?F3# MLPFWD=MTVQRTN6D+VWK:9MDVVWY@>\%VUL[>+M%.9[?%[I3=(WN^?;1]A?V` M_:?V#QRX#I$.:H"6[[;* M;=SMOL!2(!4T"?8*;KLSW*/<:]Q'W:]Z$#W$'I4>6SV^](0]@SS+/4<\+WK! M7L%>:J^M7I>\"=ZAWEKO4>\;0KHP1E@GW"N<\N'[I/IT^(S[//9U\2WTW>![ MUO>U7Y!?E=^8WRT11Y0LZA`=$WWG[^DO]Q_QOQK`"$@(:`LX$O!MH%>@,G!; MX)^#N$%I0:N"3@;](S@D6!^\/_A!B$M(22@A-#:T+?3C MT!=AP6&&L(-A?P\7AE>&[PF_OT"P0+E@;,'="*<(6<2.B,E(++(D\OW(R2C' M*%G4:-0WT<[1BNB=T?=B/&(J8O;%/([UB]7'?A3[3!(F628Y'H?$)<9UQTW$ M<^)SXX?COTYP2E`E[$V820Q*;$X\GD1(2DG:D'1#:B>52W=+9Y)#DIN2S=9$U:SJ69&GZ+?60O5+JD]8N#A/U,7C.[&E<:I MNLBZD;KG]7GUAQK8#=J&"XV>C6L:[S4E-/VF&6V6-Y]L<6QI;YE:%K-L1RO4 M6MIZLLVYK;-M>GGB\EWMU/;*]C]U^'7T=WR_(G_%L4Z[SN6==U=VMZ/ZBQZ]GL.>'7GGO%VM%:X?6_KBN;-U$ M7W#?MO7$]=KUUS=$;=C5S^YOZK^[,6WCX0%LH'O@^TW%F\X-!@YNWTS=;-P\ M.93Z3P"D`5O^F+B9))F0F?R::)K5FT*;KYP0)ZNGQV?BY_Z MH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ M'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0E MM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^ M_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+QHM\IWZ_@-N"] MX43AS.)3XMOC8^/KY'/D_.6$Y@WFENV<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX M^2A4:6UE'1' M4W1A=&4O4T$@9F%LFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB,RXQ+3&UL;G,Z>&%P/2)H='1P.B\O;G,N861O M8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L;"!697)S:6]N(#4N M,BXR/"]X87`Z0W)E871O&UL.FQA;F<](G@M9&5F875L="(^36EC&%P34TZ26YS=&%N8V5)1#YU=6ED.C(W.3@Q86-D+64P83(M-&0Q M,RUB9#$T+3=F,C=D,3@T-S`X83PO>&%P34TZ26YS=&%N8V5)1#X*("`@("`@ M/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO -----END PRIVACY-ENHANCED MESSAGE-----